FINAL PROGRAM - Society for Immunotherapy of Cancer
FINAL PROGRAM - Society for Immunotherapy of Cancer
FINAL PROGRAM - Society for Immunotherapy of Cancer
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Poster Listings<br />
46<br />
IMPROVED IN VIVO PERSISTENCE OF CD19-<br />
SPECIFICT CELLS EXPRESSING A MEMBRANE-<br />
BOUND FORM OF IL-15<br />
Lenka V. Hurton 1 , Kirsten Switzer 1 , Harjeet Singh 1 , Tiejuan Mi 1 , Simon<br />
Olivares 1 , Dean Lee 2 , Laurence JN Cooper 2<br />
1<br />
Pediatrics-Research, M.D. Anderson <strong>Cancer</strong> Center, The University <strong>of</strong><br />
Texas-Houston, Houston, TX<br />
2<br />
Pediatrics-Patient Care, M.D. Anderson <strong>Cancer</strong> Center, The University<br />
<strong>of</strong> Texas-Houston, Houston, TX<br />
47<br />
SIMPLIFIED METHOD OFTHE GROWTH OFTUMOR<br />
INFILTRATING LYMPHOCYTES (TIL) IN GAS-<br />
PERMEABLE FLASKSTO NUMBERS NEEDED FOR<br />
PATIENTTREATMENT<br />
Jianjian Jin 1 , Marianna Sabatino 1 , Robert Somerville 2 , John R. Wilson 3 ,<br />
Mark E. Dudley 2 , David F. Stroncek 1 , Steven A. Rosenberg 2<br />
1<br />
Cell Processing Section, Department <strong>of</strong> Transfusion Medicine, Clinical<br />
Center, NIH, Bethesda, MD<br />
2<br />
Surgery Branch, National <strong>Cancer</strong> Institute, NIH, Bethesda, MD<br />
3<br />
Wilson Wolf Manufacturing Corporation, New Brighton, MN<br />
48<br />
CD56 EPITOPE ESCAPE ONT CELLS ALLOWS FOR<br />
NUMERIC EXPANSION OF CD56-SPECIFICT CELLS<br />
WITHOUT AUTOLYSIS<br />
Denise Kellar, Sonny Ang, Simon Olivares, Helen Huls, Laurence<br />
Cooper<br />
U.T. MD Anderson <strong>Cancer</strong> Center, Houston, TX<br />
49<br />
WITHDRAWN BY AUTHOR<br />
50<br />
REDIRECTED ANTI-TUMOR ACTIVITY OF PRIMARY<br />
HUMAN LYMPHOCYTESTRANSDUCED WITH<br />
A FULLY-HUMAN ANTI-MESOTHELIN CHIMERIC<br />
RECEPTOR<br />
Evripidis Lanitis 1,2 , Mathilde Poussin 1 , Ian S. Hagemann 3 , George<br />
Coukos 1 , Raphael M. Sandaltzopoulos 2 , Nathalie Scholler 1 , Daniel J.<br />
Powell Jr. 1,3<br />
1<br />
Obstetrics and Gynecology, University <strong>of</strong> Pennsylvania, Ovarian <strong>Cancer</strong><br />
Research Center, Philadelphia, PA<br />
2<br />
Democritus University <strong>of</strong> Thrace, Molecular Biology and Genetics,<br />
Alexandroupolis, Greece<br />
3<br />
Pathology and Laboratory Medicine, University <strong>of</strong> Pennsylvania,<br />
Abramson <strong>Cancer</strong> Center, Philadelphia, PA<br />
51<br />
TUMOR LACTIC ACIDOSIS SUPPRESSES CTL<br />
FUNCTION BY INHIBITION OF P38 AND JNK/C-JUN<br />
ACTIVATION<br />
Anna Mendler, Bin Hu, Petra Prinz, Petra Skrablin, Elfriede Noessner<br />
Helmholtz Center Munich, Institute <strong>of</strong> Molecular Immunology, Munich,<br />
Germany<br />
52<br />
HUMAN ANTI CANCER CYTOKINE INDUCED<br />
KILLER CELLS AND THEIR INTERACTION WITH THE<br />
HOST IMMUNE SYSTEM<br />
Silvia Coin 1 , Irene Cavattoni 2 , Enrico Morello 2 , Carlo Laudanna 1 ,<br />
Alessio Montresor 1 , Alice Pievani 3 , Vincenzo Bronte 1 , Sergio<br />
Cortelazzo 2 , Alessandro Rambaldi 3 , Martino Introna 3 , Vladia<br />
Monsurrò 1<br />
1<br />
Pathology and Diagnostic, University <strong>of</strong> Verona Medical School, Verona,<br />
Italy<br />
2<br />
Hematology, Azienda Sanitaria dell’Alto Adige, Bolzano, Italy<br />
3<br />
Cellular Therapy, Ospedali Riuniti di Bergamo, Bergamo, Italy<br />
53<br />
GENERATION AND OPTIMIZATION OF A CHIMERIC<br />
ANTIGEN RECEPTOR AGAINST CD22: A NEW<br />
IMMUNOTHERAPEUTIC AGENT FORTREATING B<br />
LINEAGE LEUKEMIA AND LYMPHOMA<br />
Waleed Haso 1 , Ira Pastan 2 , Richard Morgan 3 , Crystal Mackall 1 , Rimas<br />
J. Orentas 1<br />
1<br />
Pediatric Oncology Branch, National <strong>Cancer</strong> Institute, CCR, Bethesda,<br />
MD<br />
2<br />
Laboratory <strong>of</strong> Molecular Biology, National <strong>Cancer</strong> Institute, CCR,<br />
Bethesda, MD<br />
3<br />
Surgery Branch, National <strong>Cancer</strong> Institute, CCR, Bethesda, MD<br />
62<br />
<strong>FINAL</strong> <strong>PROGRAM</strong> • SITC 26 TH ANNUAL MEETING<br />
November 4-6, 2011 • North Bethesda, MD • www.sitcancer.org
Change language